Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection

• Sha Huang ,

  ¶‡ These authors are co-first authors on this work.

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Gui-Qian Huang ,

  ¶‡ These authors are co-first authors on this work.

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, Renji School of Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Gui-Qi Zhu ,

  ¶‡ These authors are co-first authors on this work.

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Wen-Yue Liu,

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, Department of Endocrinology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Jie You,

  Affiliation Department of Oncological Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Ke-Qing Shi,

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, Institute of Hepatology, Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Xiao-Bo Wang,

  Affiliation Intensive Care Unit, Wenzhou Central Hospital, Wenzhou 325000, China

  ⨯
• Han-Yang Che,

  Affiliation Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Guo-Liang Chen,

  Affiliation Department of General Surgery, Jinhua People’s Hospital, Jinhua 321000, China

  ⨯
• Jian-Feng Fang,

  Affiliation Department of Hepatobiliary Surgery, Shaoxing People’s Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing 312000, China

  ⨯
• Yi Zhou,

  Affiliations School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou 325000, China, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Meng-Tao Zhou,

  Affiliation Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Yong-Ping Chen,

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, Institute of Hepatology, Wenzhou Medical University, Wenzhou 325000, China

  ⨯
• Martin Braddock,

  Affiliation Global Medicines Development, AstraZeneca R&D, Alderley Park, Macclesfield, United Kingdom

  ⨯
• Ming-Hua Zheng

  * E-mail: blueman1320@163.com

  Affiliations Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China, Institute of Hepatology, Wenzhou Medical University, Wenzhou 325000, China

  ⨯